Skip to main content
. 2023 Oct 31;8(45):43088–43098. doi: 10.1021/acsomega.3c06508

Table 2. In Vitro Cytotoxicity and Trypanocidal Activity of Nitrofuryl- (1a9a) and Nitrothienylazines (1b9b)e.

reference drug/compound # cytotoxicityCC50 ± SD(μM)a trypanocidal activityIC50 ± SD(μM)b(SI)c
MDBK Tbb GuTat3.1 Tbg IL1922 Tbr IL1501 Teq IVM-t1 Tev Tansui Tc IL3000
Nitrofurantoin
  73.02 ± 36.15 1.51 ± 0.03 (48) 1.85 ± 0.23 (39) 1.69 ± 0.20 (43) 1.45 ± 0.03 (50) 1.67 ± 0.07 (44) 0.42 ± 0.05 (174)
Nitrofurylazines
1a 11.59 ± 1.52 3.94 ± 2.08 (3) 4.00 ± 1.11 (3) 4.00 ± 1.09 (3) 3.49 ± 1.89 (3) 3.71 ± 2.04 (3) 0.19 ± 0.08 (61)
2a 33.92 ± 22.17 2.03 ± 0.95 (17) 2.48 ± 0.67 (14) 2.42 ± 0.40 (14) 2.46 ± 0.70 (14) 2.66 ± 1.02 (13) 0.18 ± 0.07 (188)
3a >360.15 1.02 ± 0.43 (>353) 1.20 ± 0.24 (>300) 1.26 ± 0.15 (>286) 1.18 ± 0.17 (>305) 1.78 ± 0.46 (>202) 0.14 ± 0.05 (>2 572)
4a >310.45 0.76 ± 0.35 (>408) 0.81 ± 0.20 (>383) 0.86 ± 0.23 (>361) 0.71 ± 0.18 (>437) 1.15 ± 0.16 (>270) 0.04 ± 0.01 (>7 761)
5a >388.74 3.25 ± 1.94 (>120) 3.68 ± 1.43 (>106) 3.71 ± 1.30 (>105) 4.04 ± 0.53 (>96) 5.43 ± 1.08 (>72) 0.18 ± 0.05 (>2 160)
6a 41.14 ± 3.15 2.68 ± 1.37 (15) 3.43 ± 1.20 (12) 2.88 ± 0.51 (14) 3.15 ± 0.53 (13) 4.06 ± 1.50 (10) 0.22 ± 0.08 (187)
7a >286.25 0.50 ± 0.35 (>573) 0.46 ± 0.07 (>622) 0.55 ± 0.10 (>520) 0.52 ± 0.09 (>550) 0.62 ± 0.04 (>462) 0.03 ± 0.01 (>9 542)
8a 18.44 ± 2.51 3.89 ± 2.14 (5) 5.47 ± 0.23 (3) 4.81 ± 1.10 (4) 5.01 ± 1.18 (4) 6.83 ± 2.66 (3) 0.20 ± 0.07 (92)
9a 24.56 ± 15.79 1.29 ± 0.38 (19) 1.50 ± 0.28 (16) 1.31 ± 0.04 (19) 1.24 ± 0.46 (20) 1.74 ± 0.74 (14) 0.17 ± 0.06 (144)
Nitrothienylazines
1b 10.37 ± 1.97 0.30 ± 0.10 (35) 0.34 ± 0.01 (31) 0.35 ± 0.02 (30) 0.33 ± 0.09 (31) 0.42 ± 0.02 (25) 0.10 ± 0.04 (104)
2b 87.96 ± 66.83 0.46 ± 0.20 (191) 0.57 ± 0.08 (154) 0.59 ± 0.07 (149) 0.57 ± 0.11 (154) 0.67 ± 0.02 (131) 0.06 ± 0.03 (1 466)
3b >340.45 0.84 ± 0.42 (>405) 1.04 ± 0.23 (>327) 0.95 ± 0.27 (>358) 1.23 ± 0.16 (>277) 1.34 ± 0.02 (>254) 0.14 ± 0.06 (>2 432)
4b >295.70 0.82 ± 0.45 (>361) 1.01 ± 0.25 (>293) 0.94 ± 0.31 (>315) 1.04 ± 0.35 (>384) 1.83 ± 0.54 (>162) 0.12 ± 0.03 (>2 464)
5b >365.88 2.09 ± 1.21 (>175) 2.50 ± 0.81 (>146) 2.07 ± 0.99 (>177) 3.39 ± 0.44 (>108) 5.17 ± 1.58 (>232) 0.35 ± 0.10 (>1 045)
6b >345.65 1.05 ± 0.48 (>329) 1.29 ± 0.20 (>268) 1.30 ± 0.21 (>177) 2.10 ± 0.41 (>165) 2.65 ± 0.42 (>232) 0.22 ± 0.04 (>1 571)
7b >273.67 4.88 ± 4.20 (>56) 4.60 ± 0.73 (>59) 4.10 ± 1.13 (>67) 10.51 ± 3.76 (>26) 12.30 ± 2.96 (>22) 0.28 ± 0.08 (>977)
8b 9.26 ± 2.36 0.33 ± 0.12 (28) 0.43 ± 0.14 (22) 0.37 ± 0.05 (25) 0.50 ± 0.09 (19) 0.61 ± 0.02 (15) 0.04 ± 0.01 (232)
9b >328.64 0.91 ± 0.51 (>361) 0.97 ± 0.19 (>339) 0.93 ± 0.23 (>353) 1.01 ± 0.50 (>325) 1.41 ± 0.20 (>233) 0.06 ± 0.02 (>5 477)
Reference drugsd
eflornithine - 38.56 ± 9.88 36.66 ± 12.87 45.99 ± 17.07 - 57.21 ± 17.56 16.13 ± 2.93
nifurtimox - 4.66 ± 19.70 4.58 ± 2.38 4.35 ± 1.59 - 2.62 ± 1.40 1.06 ± 0.22
pentamidine - 0.041 ± 0.0023 0.014 ± 0.0031 0.029 ± 0.0062 0.0013 ± 0.0003 0.00097 ± 0.00019 0.33 ± 0.05
suramin - 0.066 ± 0.0052 0.064 ± 0.0018 0.076 ± 0.011 0.038 ± 0.014 0.38 ± 0.058 7.17 ± 0.87
diminazene aceturate - - - - 0.011 ± 0.0029 - 0.109 ± 0.026
a

Half-maximal cytotoxic concentration (IC50, μM) represented as the mean ± standard deviation (SD), three biological replicates.

b

Half-maximal inhibitory concentration (IC50, μM) represented as the mean ± standard deviation (SD), four biological replicates.

c

Selectivity index (SI): CC50 of MDBK/IC50 of trypanosome.

d

IC50 values obtained from the literature.42,51,52.

e

MDBK: Madin–Darby bovine kidney cells; Tbb: Trypanosoma brucei brucei; Tbg: Trypanosoma brucei gambiense; Tbr: Trypanosoma brucei rhodesiense; Teq: Trypanosoma equiperdum; Tev: Trypanosoma evansi; Tc: Trypanosoma congolense; qualifies as trypanocidal hit if IC50 ≤ 10 μM and SI ≥ 10.53